| 000 | 00939 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513200131.0 | ||
| 264 | 0 | _c19991216 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0964-3397 | ||
| 024 | 7 |
_a10.1016/s0964-3397(99)80008-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacConnachie, A M | |
| 245 | 0 | 0 |
_aTreatment of hepatitis C infection. _h[electronic resource] |
| 260 |
_bIntensive & critical care nursing _cApr 1999 |
||
| 300 |
_a115-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHepatitis C _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tIntensive & critical care nursing _gvol. 15 _gno. 2 _gp. 115-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0964-3397(99)80008-1 _zAvailable from publisher's website |
| 999 |
_c10551125 _d10551125 |
||